Choksi Laboratories gains on plan to incorporate wholly owned foreign subsidiary in USA

18 Jun 2014 Evaluate

Choksi Laboratories is currently trading at Rs 11.70, up by 0.52 points or 4.65% from its previous closing of Rs 11.18 on the BSE.

The scrip opened at Rs 11.70 and has touched a high and low of Rs 11.70 and Rs 10.69 respectively. So far 6571 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 11.50 on 16-Jun-2014 and a 52 week low of Rs. 5.25 on 22-Mar-2014.

Last one week high and low of the scrip stood at Rs 11.50 and Rs. 9.95 respectively. The current market cap of the company is Rs. 8.15 crore.

The promoters holding in the company stood at 31.47% while Non-Institutions held 68.53%.

Choksi Laboratories has received an approval to incorporate a wholly owned foreign subsidiary of the company in United State of America (USA). The board of directors at its meeting held on June 16, 2014 has approved for the same.

The board also approved to increase the authorize share capital of the company from Rs 10 crore to Rs 15 crore subject to approval of shareholder in general meeting.

Choksi Laboratories is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.

 

Choksi Lab Share Price

118.40 -3.65 (-2.99%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×